CN111420278B - Intelligent migraine therapeutic instrument - Google Patents
Intelligent migraine therapeutic instrument Download PDFInfo
- Publication number
- CN111420278B CN111420278B CN202010287996.4A CN202010287996A CN111420278B CN 111420278 B CN111420278 B CN 111420278B CN 202010287996 A CN202010287996 A CN 202010287996A CN 111420278 B CN111420278 B CN 111420278B
- Authority
- CN
- China
- Prior art keywords
- triode
- pin
- chip
- resistor
- circuit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/025—Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
- Y02D30/00—Reducing energy consumption in communication networks
- Y02D30/70—Reducing energy consumption in communication networks in wireless communication networks
Abstract
The invention discloses an intelligent migraine therapeutic apparatus, which comprises a patch, a component mounting panel and a top panel, wherein the component mounting panel is fixedly mounted on the upper end surface of the patch, the top panel is fixedly mounted with the upper end surface of the component mounting panel, and a key switch is additionally mounted at the upper end of the top panel. The intelligent migraine therapeutic apparatus provided by the invention has the following advantages: the advantages are as follows: the migraine is treated by adopting a physical method, and the treatment result can be fed back to the mobile phone App to display treatment data without medicines during treatment. The advantages are as follows: according to the requirements of the user, the magnitude of the output current amplitude of the treatment circuit is adjusted so as to switch to a required mode, thereby meeting the requirements of the user. The method has the following advantages: the structure is small and exquisite, the use is comfortable and convenient, and the electrified stability is high.
Description
Technical Field
The invention relates to the technical field of migraine therapeutic apparatuses, in particular to an intelligent migraine therapeutic apparatus.
Background
Migraine is the most common neurological disorder characterized by recurrent headache with associated gastrointestinal symptoms and sensory fear. Migraine is a sixth disabling disease in the world according to 2013 global disease burden study, due to disabling headache and related symptoms, which significantly impairs quality of life. Currently, there is no exact means to cure migraine, but various treatments are available to control the disease. Control of migraine includes acute and prophylactic treatment: the purpose of acute treatment is to block attacks and restore normal function, while prophylactic treatment is to achieve the goal of reducing the frequency and severity of attacks while alleviating the disease. Currently, migraine management is mainly treated with drugs. The most commonly used drugs that block migraine attacks are analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) and triptans. Useful prophylactic agents include beta-blockers (e.g., metoprolol, propranolol, bisoprolol, candesartan), calcium channel blockers (e.g., flunarizine or verapamil) and anticonvulsants (e.g., topiramate and sodium valproate), while nutraceutical products (e.g., riboflavin, coenzyme Q10, magnesium or Compositae) have lower therapeutic effects. Most prophylactic anti-migraine drugs have contraindications and moderate to severe side effects. Importantly, these side effects combine poorly with efficacy, often resulting in dissatisfaction and withdrawal from treatment. In a large survey of U.S. health insurance, patients beginning to use antidepressants, anticonvulsants, and beta-blockers to prevent migraine headaches were assigned to discontinuation of therapy after 6 months, 73.4%, 70.2%, and 67.6% of the individuals, respectively. In patients with frequent and/or long-term migraine attacks, excessive use of acute anti-migraine medications can lead to headache chronicity, i.e.: headache is caused by overuse of the medicine, thereby worsening the illness state. In addition, some patients (particularly chronic migraine patients) develop resistance, and thus, adequate pain relief cannot be achieved using conventional drug treatment and prevention. In summary, 80% of patients would like to change their current therapeutic drugs if the efficacy was similar with fewer side effects. Thus, drug-related adverse effects and lack of efficacy underscores the need for better anti-migraine treatments, creating opportunities for non-drug therapies (e.g., nerve stimulation). Based on this, an intelligent migraine therapeutic apparatus is proposed.
Disclosure of Invention
The invention aims to provide an intelligent migraine therapeutic apparatus, which adopts a physical method to treat migraine without medicines, and can feed back therapeutic results to a mobile phone App to display therapeutic data; the magnitude of the output current amplitude of the treatment circuit can be adjusted according to the requirements of users so as to switch to a required mode, thereby meeting the requirements of the users; the device has the advantages of small structure, comfortable and convenient use and high electrified stability, and solves the problems of serious adverse reactions caused by the adoption of drug treatment in the prior art.
In order to achieve the above purpose, the present invention provides the following technical solutions: an intelligent migraine therapeutic apparatus comprises a patch, a component mounting panel and a top panel, wherein the component mounting panel is fixedly mounted on the upper end surface of the patch, the top panel is fixedly mounted with the upper end surface of the component mounting panel, and a key switch is mounted on the upper end of the top panel; the components and parts of top panel lower extreme install integrated microcontroller in the panel inner chamber additional, power supply circuit, treatment circuit, lithium cell charging circuit, USB interface circuit, touch switch circuit, bluetooth low energy circuit and buzzer prompt circuit all with microcontroller electric connection.
Preferably, the power supply circuit adopts a chip IC1, the type of the chip IC1 is TPS73101, the pin 1 of the chip IC1 is connected to the vbat+ power supply terminal input and connected to the input end of the capacitor C4, the pin 5 of the chip IC1 outputs 2.4V power and is connected to the output end of the resistor R4, the input end of the resistor R4 is connected to the pin 4 of the chip IC1 and is connected to the input end of the resistor R5, and the output end of the resistor R5, the output end of the capacitor C4 and the pin 2 of the chip IC1 are connected to ground.
Preferably, the microcontroller uses a chip IC2 as a main chip, a pin 28 of the chip IC2 is connected to a pin 2 of the pin header JP1, a pin 21 of the chip IC2 is connected to a No. 3 terminal of the LED1, and a No. 4 terminal of the LED1 is connected to a 2.4V power input terminal.
Preferably, the therapeutic circuit comprises a triode Q1-triode Q12, a reverse voltage-withstanding tube D1-reverse voltage-withstanding tube D3, wherein the base electrode of the triode Q1 is connected to a pin 8 of the chip IC2, the emitter electrode of the triode Q1 is grounded, the collector electrode of the triode Q1 is connected to the output end of the inductor L1 and is connected to the positive electrode of the reverse voltage-withstanding tube D1, and the input end of the inductor L1 is connected to the power input end VBAT+; the base electrode of the triode Q3 is connected to the pin 12 of the chip IC2, the emitter electrode of the triode Q3 is grounded, the collector electrode of the triode Q3 is connected to the negative electrode of the reverse voltage-resistant tube D1 and is connected to the base electrode of the triode Q2 and the base electrode of the triode Q7, the negative electrode of the reverse voltage-resistant tube D1 is connected to the input end of the resistor R14, the output end of the resistor R14 is connected to the input end of the resistor 16, the output end of the resistor R16 is connected to the pin 19 of the chip IC2, the emitter electrode of the triode Q2 is connected with the base electrode of the triode Q4, and the collector electrode of the triode Q2 is connected with the collector electrode of the triode Q4 and then is connected with the TREAT-OUT-/+ terminal for output; the emitter of the triode Q4 is connected with the emitter of the triode Q5 and is connected to the negative electrode of the reverse voltage-resistant tube D1 and the collector of the triode Q12, the base of the triode Q5 is connected with the emitter of the triode Q6, the collector of the triode Q5 is connected with the collector of the triode Q6 and then is connected to a TREAT-OUT +/-terminal for output, and the base of the triode Q6 is connected to the collector of the triode Q12; the emitter of the triode Q12 is grounded, the collector of the triode Q12 is connected with a resistor R24 in series and then is connected to a pin 13 of the chip IC2, the collector of the triode Q12 is connected to the base of a triode Q9, the emitter of the triode Q9 is connected with the base of a triode Q10, the emitter of the triode Q10 is connected to the negative electrode of a reverse voltage-resistant tube D3, and the positive electrode of the reverse voltage-resistant tube D3 is connected to the collector of the triode Q2; the collector of the triode Q10 is connected to the collector of the triode Q8 and the collector of the triode Q7, and is connected to the input end of a resistor R20, and the output end of the resistor R20 is connected to a pin 18 of the chip IC 2; the emitter of the transistor Q7 and the base of the transistor Q8, the emitter of the transistor Q8 is connected to the positive pole of the reverse voltage-withstanding tube D2, and the negative pole of the reverse voltage-withstanding tube D2 is connected to the emitter of the transistor Q4.
Preferably, the lithium battery charging circuit adopts a chip IC3 as a main chip, a pin 1 of the chip IC3 is connected to a No. 1 terminal of the LED1, and a pin 3 of the chip IC3 is connected to a power supply input end VBAT+.
Preferably, the pin 5 of the USB interface circuit is connected to the pin 4 of the chip IC3, and the pin 5 of the USB interface circuit is connected to the pin 2 and then grounded.
Preferably, the touch switch circuit includes a switch SW1, a resistor R6, a resistor R8 and a resistor R9, where the pin 1 of the switch SW1 is connected to the pin 2 and then to the power input vbat+, the pin 6 of the switch SW1 is connected to the output of the resistor R6, the input of the resistor R6 is connected to the pin 14 of the chip IC2, the pin 4 of the switch SW1 is connected to the input of the resistor R8, the output of the resistor R8 is connected to the input of the resistor R9 and is connected to the pin 16 of the chip IC2, and the output of the resistor R9 is grounded.
Preferably, the bluetooth low energy circuit adopts a chip BLE1, the model of the chip BLE1 is BF-BM-4044B4, a pin 15 of the chip BLE1 is grounded, a pin 1 of the chip BLE1 is connected to a pin 2 of the chip IC2, a pin 2 of the chip BLE1 is connected to a pin 3 of the chip IC2, a pin 3 of the chip BLE1 is connected to a pin 26 of the chip IC2, a pin 4 of the chip BLE1 is connected to a pin 27 of the chip IC2, a pin 8 of the chip BLE1 is connected to a pin 15 of the chip IC2, a pin 12 of the chip BLE1 is connected to a pin 24 of the chip IC2, and a pin 13 of the chip BLE1 is connected to a pin 25 of the chip IC 2.
Preferably, the buzzer prompt circuit adopts a buzzer BZ1 and a triode Q13, the pin 1 of the buzzer BZ1 is connected to the 2.4V power input end, the pin 2 of the buzzer BZ1 is connected to the collector of the triode Q13, the emitter of the triode Q13 is grounded, the base of the triode Q13 is connected to the output end of a resistor R23, and the input end of the resistor R23 is connected to the pin 4 of the chip IC 2.
Compared with the prior art, the invention has the beneficial effects that: the intelligent migraine therapeutic apparatus provided by the invention has the following advantages:
the advantages are as follows: the migraine is treated by adopting a physical method, no medicine is needed during treatment, connection is established between the mobile phone App and the low-power consumption Bluetooth circuit, and the treatment result is fed back to the mobile phone App to display treatment data.
The advantages are as follows: the magnitude of the current amplitude of the treatment circuit can be adjusted, so that the intelligent migraine therapeutic apparatus has various working modes, and the magnitude of the current amplitude of the treatment circuit is adjusted according to the requirements of users so as to switch to the required mode, thereby meeting the requirements of the users.
The method has the following advantages: the patch has the advantages that the patch is small in structure and convenient to use, the bottom surface of the patch is set into an intrados shape according to the head shape of a human body, the patch can be well attached to the surface of the human body when in use, the patch is comfortable to use, and the electrode plate connected with the patch is effectively attached to the surface of the human body, so that the electrified stability is ensured, and the stability to the treatment process is ensured.
Drawings
FIG. 1 is a schematic diagram of the overall structure of the present invention;
FIG. 2 is a schematic block diagram of the circuit of the present invention;
FIG. 3 is a diagram of a power supply circuit of the present invention;
FIG. 4 is a diagram of a microcontroller according to the present invention;
FIG. 5 is a therapeutic circuit diagram of the present invention;
fig. 6 is a diagram of a lithium battery charging circuit according to the present invention;
FIG. 7 is a circuit diagram of a USB interface of the present invention;
FIG. 8 is a circuit diagram of a touch switch of the present invention;
fig. 9 is a low-power bluetooth circuit diagram according to the present invention;
fig. 10 is a buzzer alert circuit diagram of the present invention.
In the figure: 1. a patch; 2. the components are additionally provided with a panel; 3. a top panel; 4. a key switch; 5. a microcontroller; 6. a power supply circuit; 7. a treatment circuit; 8. a lithium battery charging circuit; 9. a USB interface circuit; 10. a touch switch circuit; 11. a low-power Bluetooth circuit; 12. a buzzer prompt circuit.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Referring to fig. 1-10, an intelligent migraine therapeutic apparatus comprises a patch 1, a component mounting panel 2 and a top panel 3, wherein the component mounting panel 2 is fixedly mounted on the upper end surface of the patch 1, the top panel 3 is fixedly mounted with the upper end surface of the component mounting panel 2, and a key switch 4 is mounted on the upper end of the top panel 3; the components and parts of top panel 3 lower extreme installs integrated microcontroller 5, power supply circuit 6, treatment circuit 7, lithium cell charging circuit 8, USB interface circuit 9, touch switch circuit 10, bluetooth low energy circuit 11 and buzzer suggestion circuit 12 in the panel 2 inner chamber additional, and power supply circuit 6, treatment circuit 7, lithium cell charging circuit 8, USB interface circuit 9, touch switch circuit 10, bluetooth low energy circuit 11 and buzzer suggestion circuit 12 all are with microcontroller 5 electric connection.
The power supply circuit 6 adopts a chip IC1, the type of the chip IC1 is TPS73101, the pin 1 of the chip IC1 is connected to vbat+ power supply terminal input and connected to the input end of the capacitor C4, the pin 5 of the chip IC1 outputs 2.4V power and is connected to the output end of the resistor R4, the input end of the resistor R4 is connected to the pin 4 of the chip IC1 and is connected to the input end of the resistor R5, the output end of the capacitor C4 and the pin 2 of the chip IC1 are connected to ground, and the power supply circuit 6 provides power for the operation of each operation component.
The microcontroller 5 adopts the chip IC2 as a main chip, the pin 28 of the chip IC2 is connected to the pin 2 of the pin JP1, the pin 21 of the chip IC2 is connected to the No. 3 terminal of the LED1, the No. 4 terminal of the LED1 is connected with the 2.4V power input end, and the microcontroller is used for controlling the operation of the treatment circuit 7, feeding back the treatment information and sounding an alarm when in abnormal operation.
The treatment circuit 7 comprises a triode Q1-triode Q12, a reverse voltage-withstanding tube D1-reverse voltage-withstanding tube D3, wherein the base electrode of the triode Q1 is connected to a pin 8 of the chip IC2, the emitter electrode of the triode Q1 is grounded, the collector electrode of the triode Q1 is connected to the output end of the inductor L1 and is connected to the positive electrode of the reverse voltage-withstanding tube D1, and the input end of the inductor L1 is connected to the power supply input end VBAT+; the base electrode of the triode Q3 is connected to the pin 12 of the chip IC2, the emitter electrode of the triode Q3 is grounded, the collector electrode of the triode Q3 is connected to the negative electrode of the reverse voltage-resistant tube D1 and is connected to the base electrode of the triode Q2 and the base electrode of the triode Q7, the negative electrode of the reverse voltage-resistant tube D1 is connected to the input end of the resistor R14, the output end of the resistor R14 is connected to the input end of the resistor 16, the output end of the resistor R16 is connected to the pin 19 of the chip IC2, the emitter electrode of the triode Q2 is connected with the base electrode of the triode Q4, and the collector electrode of the triode Q2 is connected with the collector electrode of the triode Q4 and then is connected with the TREAT-OUT-/+ terminal for output; the emitter of the triode Q4 is connected with the emitter of the triode Q5 and is connected to the negative electrode of the reverse voltage-resistant tube D1 and the collector of the triode Q12, the base electrode of the triode Q5 is connected with the emitter of the triode Q6, the collector of the triode Q5 is connected with the collector of the triode Q6 and then is connected to a TREAT-OUT +/-terminal for output, and the base electrode of the triode Q6 is connected to the collector of the triode Q12; the emitter of the triode Q12 is grounded, the collector of the triode Q12 is connected with a resistor R24 in series and then is connected to a pin 13 of the chip IC2, the collector of the triode Q12 is connected to the base of the triode Q9, the emitter of the triode Q9 is connected with the base of the triode Q10, the emitter of the triode Q10 is connected to the negative electrode of a reverse voltage-withstanding tube D3, and the positive electrode of the reverse voltage-withstanding tube D3 is connected to the collector of the triode Q2; the collector of the triode Q10 is connected to the collector of the triode Q8 and the collector of the triode Q7, and is connected to the input end of a resistor R20, and the output end of the resistor R20 is connected to a pin 18 of the chip IC 2; the emitter of the transistor Q7 and the base of the transistor Q8, the emitter of the transistor Q8 is connected to the positive pole of the reverse voltage-withstanding tube D2, the negative pole of the reverse voltage-withstanding tube D2 is connected to the emitter of the transistor Q4, when the electrode slice connected by the diode D2 and the electrode slice connected by the output end of the diode D3 are attached to the surface of a human body, a treatment loop is formed, the human body is electrified as a conductor, so that micro-current stimulation treatment is carried out on the human body, and the treatment effect is achieved; the AD sampling port of the microcontroller 5 collects the voltage on the resistor R14 connected with the collector of the triode Q1, related current is calculated through the collected voltage, the microcontroller 5 adjusts the amplitude of output voltage according to the obtained current to control the duty ratio or period of PWM pulse signals of the base of the triode Q6, and therefore the purpose of adjusting the amplitude of the current of the treatment circuit 7 is achieved, and the intelligent migraine therapeutic apparatus can work in various modes by adjusting the amplitude of the current.
The above-mentioned lithium battery charging circuit 8 adopts the chip IC3 as the main chip, and the foot 1 of chip IC3 is connected to the No. 1 terminal of LED1, and the foot 3 of chip IC3 is connected to power input vbat+, and lithium battery charging circuit 8 is used for charging for inside lithium battery.
The pin 5 of the USB interface circuit 9 is connected to the pin 4 of the chip IC3, and the pin 5 of the USB interface circuit 9 is connected to the pin 2 and then grounded, and is electrically chargeable by the USB interface circuit 9, and is used for transmitting therapeutic data.
The touch switch circuit 10 includes a switch SW1, a resistor R6, a resistor R8, and a resistor R9, where the switch SW1 is a key switch 4, and is assembled on the top of the top panel 3, the pin 1 of the switch SW1 is connected to the pin 2 and then is connected to the power input vbat+, the pin 6 of the switch SW1 is connected to the output of the resistor R6, the input of the resistor R6 is connected to the pin 14 of the chip IC2, the pin 4 of the switch SW1 is connected to the input of the resistor R8, the output of the resistor R8 is connected to the input of the resistor R9 and is connected to the pin 16 of the chip IC2, and the output of the resistor R9 is grounded, so as to control whether to operate by controlling the power on of the switch SW1 of the touch switch circuit 10.
The bluetooth low energy circuit 11 employs a chip BLE1, the model of the chip BLE1 is BF-BM-4044B4, a pin 15 of the chip BLE1 is grounded, a pin 1 of the chip BLE1 is connected to a pin 2 of the chip IC2, a pin 2 of the chip BLE1 is connected to a pin 3 of the chip IC2, a pin 3 of the chip BLE1 is connected to a pin 26 of the chip IC2, a pin 4 of the chip BLE1 is connected to a pin 27 of the chip IC2, a pin 8 of the chip BLE1 is connected to a pin 15 of the chip IC2, a pin 12 of the chip BLE1 is connected to a pin 24 of the chip IC2, a pin 13 of the chip BLE1 is connected to a pin 25 of the chip IC2, and a connection is established with the mobile phone App through the bluetooth low energy circuit 11 for displaying therapeutic data.
Above-mentioned buzzer suggestion circuit 12 adopts buzzer BZ1 and triode Q13, and the foot 1 of buzzer BZ1 is connected to 2.4V power input, and the foot 2 of buzzer BZ1 is connected to triode Q13's collecting electrode, and triode Q13's projecting pole ground connection, and triode Q13's base is connected to resistance R23's output, and resistance R23's input is connected to chip IC 2's foot 4, and when microcontroller 5 detected work unusual, microcontroller 5 sent instruction control buzzer BZ1 work, and buzzer BZ1 takes place the warning.
The intelligent migraine therapeutic apparatus is characterized in that a power supply circuit 6 supplies power for the work of a microcontroller 5, a therapeutic circuit 7, a USB interface circuit 9, a touch switch circuit 10 and a low-power consumption Bluetooth circuit 11; the touch switch circuit 10 is connected with the microcontroller 5, the PWR-EN port and the KEY-MODE port of the microcontroller 5 control the on-off of the switch SW1, the switch SW1 is the KEY switch 4, the KEY switch 4 is arranged at the upper end of the top panel 3, and when in use, the KEY switch 4 is pressed to control whether the equipment is electrified or not; the pin 1 of the lithium battery charging circuit 8 is connected to the No. 1 terminal of the LED1, the LED1 is connected to the microcontroller 5, and the lithium battery charging circuit 8 is used as a standby power supply for supplying power to the microcontroller 5; the low-power-consumption Bluetooth circuit 11 is connected with the microcontroller 5, the microcontroller 5 sends an information sending instruction to the low-power-consumption Bluetooth circuit 11, bluetooth connection is established with the outside through the low-power-consumption Bluetooth circuit 11, and a control instruction is sent to the outside; the buzzer prompt circuit 12 is connected with the microcontroller 5, when the microcontroller 5 detects abnormal operation, the microcontroller 5 sends a prompt instruction to the buzzer prompt circuit 12, the buzzer prompt circuit 12 works, and the buzzer alarms to give out prompt sound.
The intelligent migraine therapeutic apparatus does not need medicines during treatment, adopts a physical method to treat migraine, establishes connection with a low-power consumption Bluetooth circuit 11 through a mobile phone App, feeds back a therapeutic result to the mobile phone App to display therapeutic data, wherein the working principle of a therapeutic circuit 7 is as follows:
the ports of the microcontroller 5 connected with the treatment circuit 7 are defined as HEAL-CH1 and HEAL-CH2, and when the microcontroller 5 contacts a human body, the microcontroller 5 controls the HEAL-CH1 and the HEAL-CH2 to output a high level with a specific width to the treatment circuit 7, the treatment circuit 7 discharges, and the human body is electrically stimulated; when HEAL-CH1 outputs a high level with a specific width, the triode Q12 is conducted, the voltage of the emitter electrode of the triode Q9 is larger than the base voltage of the triode Q10 through the voltage division of the resistor R22 and the resistor R21, the triode Q9 and the triode Q10 are conducted, the output current flows out from the emitter electrode of the triode Q10 and is output after passing through the diode D3, and the output end of the diode D3 can be attached to the surface of a human body through an electrode plate; meanwhile, HEAL-CH3 outputs a high level with a specific width, the conduction of the triode Q3 is divided by the resistor R10 and the resistor R11, so that the voltage of the emitter electrode of the triode Q7 is larger than the voltage of the base electrode of the triode Q8, the triode Q7 and the triode Q8 are conducted, the output current flows out from the emitter electrode of the triode Q8 and is output after passing through the diode D2, and the output end of the diode D2 can be connected with an electrode plate to be attached to the surface of a human body; the collector of the triode Q8 is connected and communicated with the collector of the triode Q10 and the collector of the triode Q9, when the electrode plate connected with the diode D2 and the electrode plate connected with the output end of the diode D3 are attached to the surface of a human body, a treatment loop is formed, the human body is electrified as a conductor, so that micro-current stimulation treatment is carried out on the human body, and the treatment effect is achieved; the AD sampling port of the microcontroller 5 collects the voltage on the resistor R14 connected with the collector of the triode Q1, related current is calculated through the collected voltage, the microcontroller 5 adjusts the amplitude of output voltage according to the obtained current to the duty ratio or period of PWM pulse signals controlling the base of the triode Q6, and therefore the purpose of adjusting the amplitude of the current of the treatment circuit 7 is achieved.
Mode one: partial headache patient mode—pain relief when headache occurs;
mode two: endorphin mode-enhancing endorphin production for prophylactic migraine use;
mode three: pressure relief mode-pressure relief for people with high working pressure;
mode four: promoting sleep mode-a person who is difficult to fall asleep quickly enters a sleep state;
mode five: the pleasure mode-can give people a pleasure, make people feel happy and happy, and can improve work, study, intelligence and creativity.
The intelligent migraine therapeutic apparatus has the following advantages in structure: the bottom surface of paster 1 sets up to intrados form according to human head shape, and the subsides that can be fine are on the forehead, installs components and parts additional in the up end of paster 1 installs panel 2, installs the work element at components and parts additional installs the inner chamber of panel 2 to adopt top panel 3 to seal to be solid, play fine guard action to the work element, set up key switch 4 on the top of top panel 3, conveniently press, open this intelligent migraine therapeutic apparatus, overall structure is small and exquisite, convenient to use.
In summary, the intelligent migraine therapeutic apparatus provided by the invention has the following advantages:
the advantages are as follows: the migraine is treated by adopting a physical method, no medicine is needed during treatment, the connection is established between the mobile phone App and the low-power consumption Bluetooth circuit 11, and the treatment result is fed back to the mobile phone App to display treatment data.
The advantages are as follows: the magnitude of the current amplitude of the treatment circuit 7 can be adjusted, so that the intelligent migraine therapeutic apparatus has various working modes, and the magnitude of the current amplitude output by the treatment circuit 7 is adjusted according to the requirements of users so as to switch to the required mode, thereby meeting the requirements of the users.
The method has the following advantages: the patch has the advantages that the patch is small in structure and convenient to use, the bottom surface of the patch 1 is set to be an intrados shape according to the head shape of a human body, the patch can be well attached to the surface of the human body when in use, the patch is comfortable to use, and the connected electrode plate is effectively attached to the surface of the human body, so that the electrified stability is ensured, and the stability to the treatment process is ensured.
The foregoing is only a preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art, who is within the scope of the present invention, should make equivalent substitutions or modifications according to the technical scheme of the present invention and the inventive concept thereof, and should be covered by the scope of the present invention.
Claims (5)
1. The intelligent migraine therapeutic apparatus is characterized by comprising a patch (1), a component adding panel (2) and a top panel (3), wherein the component adding panel (2) is fixedly arranged on the upper end face of the patch (1), the top panel (3) is fixedly arranged on the upper end face of the component adding panel (2), and a key switch (4) is additionally arranged at the upper end of the top panel (3); the device of the lower end of the top panel (3) is additionally provided with a microcontroller (5), a power supply circuit (6), a treatment circuit (7), a lithium battery charging circuit (8), a USB interface circuit (9), a touch switch circuit (10), a low-power Bluetooth circuit (11) and a buzzer prompt circuit (12) which are integrated in an inner cavity of the panel (2), the power supply circuit (6), the treatment circuit (7), the lithium battery charging circuit (8), the USB interface circuit (9), the touch switch circuit (10), the low-power Bluetooth circuit (11) and the buzzer prompt circuit (12) are electrically connected with the microcontroller (5), the treatment circuit (7) comprises a triode Q1-triode Q10, a triode Q12, a reverse voltage-withstanding tube D1-reverse voltage-withstanding tube D3, a triode Q1, a triode Q3, a triode Q12 are NPN-type triode Q2 and a triode Q4-triode Q10 are PNP type, the base electrode of the triode Q1 is connected to a foot 8 of the chip IC2, the emitter of the triode Q1 is grounded, the inductor Q1 is connected to the output end of the VBL 1, and the positive voltage-withstanding end is connected to the input end of the AT 1; the base electrode of the triode Q3 is connected to the pin 12 of the chip IC2, the emitter electrode of the triode Q3 is grounded, the collector electrode of the triode Q3 is connected to the negative electrode of the reverse voltage-resistant tube D1 and is connected to the base electrode of the triode Q2 and the base electrode of the triode Q7, the negative electrode of the reverse voltage-resistant tube D1 is connected to the input end of the resistor R14, the output end of the resistor R14 is connected to the input end of the resistor 16, the output end of the resistor R16 is connected to the pin 19 of the chip IC2, the emitter electrode of the triode Q2 is connected with the base electrode of the triode Q4, and the collector electrode of the triode Q2 is connected with the collector electrode of the triode Q4 and then is connected with the TREAT-OUT-/+ terminal for output; the emitter of the triode Q4 is connected with the emitter of the triode Q5 and is connected to the negative electrode of the reverse voltage-resistant tube D1 and the collector of the triode Q12, the base of the triode Q5 is connected with the emitter of the triode Q6, the collector of the triode Q5 is connected with the collector of the triode Q6 and then is connected to a TREAT-OUT +/-terminal for output, and the base of the triode Q6 is connected to the collector of the triode Q12; the emitter of the triode Q12 is grounded, the collector of the triode Q12 is connected with a resistor R24 in series and then is connected to a pin 13 of the chip IC2, the collector of the triode Q12 is connected to the base of a triode Q9, the emitter of the triode Q9 is connected with the base of a triode Q10, the emitter of the triode Q10 is connected to the negative electrode of a reverse voltage-resistant tube D3, and the positive electrode of the reverse voltage-resistant tube D3 is connected to the collector of the triode Q2; the collector of the triode Q10 is connected to the collector of the triode Q8 and the collector of the triode Q7, and is connected to the input end of a resistor R20, and the output end of the resistor R20 is connected to a pin 18 of the chip IC 2; the emitter of the transistor Q7 and the base of the transistor Q8, the emitter of the transistor Q8 is connected to the positive pole of the reverse voltage-withstanding tube D2, and the negative pole of the reverse voltage-withstanding tube D2 is connected to the collector of the transistor Q5.
2. The intelligent migraine therapeutic apparatus as set forth in claim 1, wherein: the power supply circuit (6) adopts a chip IC1, the model of the chip IC1 is TPS73101, a pin 1 of the chip IC1 is connected with a VBAT+ power supply terminal for input and is connected to an input end of a capacitor C4, a pin 5 of the chip IC1 outputs a 2.4V power supply and is connected to an output end of a resistor R4, an input end of the resistor R4 is connected to a pin 4 of the chip IC1 and is connected to an input end of the resistor R5, and the output end of the resistor R5, the output end of the capacitor C4 and a pin 2 of the chip IC1 are connected to the ground.
3. The intelligent migraine therapeutic apparatus as set forth in claim 1, wherein: the touch switch circuit (10) comprises a switch SW1, a resistor R6, a resistor R8 and a resistor R9, wherein a pin 1 of the switch SW1 is connected with a pin 2, then a power input end VBAT+ is connected with a pin 3 of the switch SW1, the input end of the resistor R6 is connected with a pin 14 of the chip IC2, a pin 4 of the switch SW1 is connected with the input end of the resistor R8, the output end of the resistor R8 is connected with the input end of the resistor R9 and is connected with a pin 16 of the chip IC2, and the output end of the resistor R9 is grounded.
4. The intelligent migraine therapeutic apparatus as set forth in claim 1, wherein: the low-power consumption Bluetooth circuit (11) adopts a chip BLE1, the model of the chip BLE1 is BF-BM-4044B4, a pin 15 of the chip BLE1 is grounded, a pin 1 of the chip BLE1 is connected to a pin 2 of the chip IC2, a pin 2 of the chip BLE1 is connected to a pin 3 of the chip IC2, a pin 3 of the chip BLE1 is connected to a pin 26 of the chip IC2, a pin 4 of the chip BLE1 is connected to a pin 27 of the chip IC2, a pin 8 of the chip BLE1 is connected to a pin 15 of the chip IC2, a pin 12 of the chip BLE1 is connected to a pin 24 of the chip IC2, and a pin 13 of the chip BLE1 is connected to a pin 25 of the chip IC 2.
5. The intelligent migraine therapeutic apparatus as set forth in claim 1, wherein: the buzzer prompt circuit (12) adopts a buzzer BZ1 and a triode Q13, the pin 1 of the buzzer BZ1 is connected to the 2.4V power input end, the pin 2 of the buzzer BZ1 is connected to the collector of the triode Q13, the emitter of the triode Q13 is grounded, the base of the triode Q13 is connected to the output end of a resistor R23, and the input end of the resistor R23 is connected to the pin 4 of the chip IC 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010287996.4A CN111420278B (en) | 2020-04-14 | 2020-04-14 | Intelligent migraine therapeutic instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010287996.4A CN111420278B (en) | 2020-04-14 | 2020-04-14 | Intelligent migraine therapeutic instrument |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111420278A CN111420278A (en) | 2020-07-17 |
| CN111420278B true CN111420278B (en) | 2023-06-16 |
Family
ID=71554259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010287996.4A Active CN111420278B (en) | 2020-04-14 | 2020-04-14 | Intelligent migraine therapeutic instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111420278B (en) |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844075A (en) * | 1984-01-09 | 1989-07-04 | Pain Suppression Labs, Inc. | Transcranial stimulation for the treatment of cerebral palsy |
| US4856526A (en) * | 1984-01-09 | 1989-08-15 | Pain Suppression Labs, Inc. | Apparatus and methodology for treatment of headache syndromes |
| JPH03123566A (en) * | 1989-10-07 | 1991-05-27 | Tokyo Electric Co Ltd | Low-frequency therapeutic apparatus |
| US5215086A (en) * | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
| CN2778315Y (en) * | 2005-04-06 | 2006-05-10 | 大庆油田总医院集团 | Dedicated portable electric ion introduction therapeutic device for hyperthyroidism |
| CN101648048A (en) * | 2008-08-12 | 2010-02-17 | 上海理工大学 | Intelligent balloon dilatation therapeutic instrument for cricopharyngeal muscle achalasia |
| CN204121597U (en) * | 2014-09-30 | 2015-01-28 | 华南理工大学 | A kind of portable electronic medical apparatus for treating menalgia |
| CN205055194U (en) * | 2015-06-24 | 2016-03-02 | 华南理工大学 | Electric pulse migraine headache therapeutic instrument |
| CN207562223U (en) * | 2017-03-23 | 2018-07-03 | 广州市千牧电子有限公司 | A kind of intelligence therapeutic equipment for sick headache |
| CN208017932U (en) * | 2017-05-13 | 2018-10-30 | 陕西诺奕生物医药科技有限公司 | A kind of control system through cranial nerve physical therapy apparatus |
| CN108768145A (en) * | 2018-05-25 | 2018-11-06 | 电子科技大学 | High speed half-bridge gate drive circuit suitable for GaN device for power switching |
| JP2019062976A (en) * | 2017-09-28 | 2019-04-25 | 日光精器株式会社 | Low frequency therapeutic device |
| CN209347931U (en) * | 2018-12-10 | 2019-09-06 | 苏州小蓝医疗科技有限公司 | A kind of patch type headache is easypro to sleep instrument |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060004423A1 (en) * | 2002-05-09 | 2006-01-05 | Boveja Birinder R | Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves |
-
2020
- 2020-04-14 CN CN202010287996.4A patent/CN111420278B/en active Active
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844075A (en) * | 1984-01-09 | 1989-07-04 | Pain Suppression Labs, Inc. | Transcranial stimulation for the treatment of cerebral palsy |
| US4856526A (en) * | 1984-01-09 | 1989-08-15 | Pain Suppression Labs, Inc. | Apparatus and methodology for treatment of headache syndromes |
| JPH03123566A (en) * | 1989-10-07 | 1991-05-27 | Tokyo Electric Co Ltd | Low-frequency therapeutic apparatus |
| US5215086A (en) * | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
| CN2778315Y (en) * | 2005-04-06 | 2006-05-10 | 大庆油田总医院集团 | Dedicated portable electric ion introduction therapeutic device for hyperthyroidism |
| CN101648048A (en) * | 2008-08-12 | 2010-02-17 | 上海理工大学 | Intelligent balloon dilatation therapeutic instrument for cricopharyngeal muscle achalasia |
| CN204121597U (en) * | 2014-09-30 | 2015-01-28 | 华南理工大学 | A kind of portable electronic medical apparatus for treating menalgia |
| CN205055194U (en) * | 2015-06-24 | 2016-03-02 | 华南理工大学 | Electric pulse migraine headache therapeutic instrument |
| CN207562223U (en) * | 2017-03-23 | 2018-07-03 | 广州市千牧电子有限公司 | A kind of intelligence therapeutic equipment for sick headache |
| CN208017932U (en) * | 2017-05-13 | 2018-10-30 | 陕西诺奕生物医药科技有限公司 | A kind of control system through cranial nerve physical therapy apparatus |
| JP2019062976A (en) * | 2017-09-28 | 2019-04-25 | 日光精器株式会社 | Low frequency therapeutic device |
| CN108768145A (en) * | 2018-05-25 | 2018-11-06 | 电子科技大学 | High speed half-bridge gate drive circuit suitable for GaN device for power switching |
| CN209347931U (en) * | 2018-12-10 | 2019-09-06 | 苏州小蓝医疗科技有限公司 | A kind of patch type headache is easypro to sleep instrument |
Non-Patent Citations (1)
| Title |
|---|
| 脑波治疗仪的理论研究与探讨;董春秋;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》(第第11期期);第E080-38页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111420278A (en) | 2020-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2459087A (en) | Sleep monitoring and inducement apparatus | |
| CN103908747A (en) | Ear vagus stimulator | |
| CN109011145A (en) | A kind of Multifunctional ear Vagus nerve stimulation instrument | |
| CN103212157A (en) | Bipolar general nerve electric stimulation instrument | |
| CN205994872U (en) | A kind of pain therapeutic equipment | |
| CN105251134A (en) | Cervical vertebra massage therapeutic instrument convenient to carry and control | |
| CN202666194U (en) | Multifunctional bladder pelvic floor rehabilitation instrument | |
| CN111420278B (en) | Intelligent migraine therapeutic instrument | |
| CN203183521U (en) | Bipolar universal electrical nerve stimulator | |
| CN203280903U (en) | Transcutaneous vagus nerve stimulation system | |
| CN210612698U (en) | Wearable wireless intelligent tibial posterior nerve electrical stimulation system | |
| CN217286901U (en) | Micro-current stimulation instrument | |
| CN205198694U (en) | Be provided with sleep appearance of display screen | |
| CN205814873U (en) | A kind of neuromuscular stimulation therapeutic instrument of function of wireless remote control | |
| CN103495261A (en) | Multifunctional therapy apparatus | |
| CN205198697U (en) | Sleep therapeutic instrument with adjustable | |
| CN203842181U (en) | Ear vagus nerve stimulator | |
| CN110038217B (en) | Wearable wireless intelligent post-tibial nerve electrical stimulation system | |
| CN204468592U (en) | A kind of multifunctional recovery bed based on somatosensory vibro-music relaxation therapy | |
| CN207304839U (en) | A kind of Headphone device for sub-health treatment | |
| CN109045470A (en) | A kind of multi-functional Frequency Adjustable low pressure negative potential pulse physiotherapy instrument | |
| CN217286517U (en) | Earphone type ear acupuncture electric acupuncture therapeutic apparatus | |
| CN205549228U (en) | Troublesome therapeutic instrument | |
| CN206381498U (en) | A kind of multi-functional electric frequency pulse therapeutic device | |
| CN215781009U (en) | Portable health care instrument of traditional chinese medical science |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |